Ethics Committee in the Netherlands Approves Parkinson’s Cannabis Trial
The cannabis-derived therapeutic candidate Parkinson's disease trial has received ethics committee approval in the Netherlands. This milestone advances clinical evidence for cannabinoid treatments in neurodegenerative conditions. Clinicians should…
From relationships to cannabis neuroscience: WWU’s podcast covers it – The Western Front
This article highlights cannabis neuroscience harm reduction as featured in WWU's podcast. It provides clinicians with evidence-based insights to counsel patients on safer cannabis use. Understanding neurobiological effects is key to effective harm…
Artelo Biosciences Advances Peripheral Cannabinoid Agonists for Glaucoma
Peripheral cannabinoid receptor agonists glaucoma research is advancing with promising synthetic compounds like ART12.11. These therapies aim to reduce intraocular pressure, a key factor in glaucoma management. Clinicians should monitor emerging data on…
Lawmakers Send Right to Try Medical Cannabis Act, Ibogaine Trials to Governor
The Right to Try Medical Cannabis Act expands patient access to cannabis outside standard trials. This legislation allows compassionate use for serious conditions. Clinicians must understand this act to guide patients on safety and legal issues.
Teenage Cannabis Use Linked to 52% Higher Schizophrenia Risk – Neuroscience News
Teenage cannabis psychosis risk is significantly elevated, with studies showing a 52% higher chance of developing schizophrenia. Adolescent cannabis use impacts brain development uniquely compared to adults. Clinicians should prioritize screening and…
Cannabis Linked to Major Memory and Health Risks – Clinical Review
Recent evidence highlights cannabis memory impairment as a significant clinical concern, particularly affecting cognitive function. Cannabis use is linked to broader health risks including cannabinoid hyperemesis syndrome. Clinicians should screen for…
The Endocannabinoid System, Immunomodulation, and LPS-Induced Inflammation
Understanding endocannabinoid system immunomodulation is critical for clinicians managing inflammatory conditions. This system regulates immune responses and inflammation triggered by lipopolysaccharide exposure. Insights into this mechanism inform…
Surprising Findings on Cannabis and Cognitive Outcomes in Older Adults
Recent research on cannabis cognitive outcomes older adults challenges previous adolescent-focused findings. Older adults may experience different cognitive effects from cannabis use, highlighting the need for age-specific clinical guidance. This…
The efficacy and safety of cannabinoids for mental disorders and substance use
This cannabinoid clinical trials mental health evidence review highlights promising but limited data on cannabinoids for mental disorders and substance use. Clinicians should weigh benefits against risks carefully. Larger trials are needed to confirm…
Cannabidiol May Help Treat Severe Alcohol Addiction and Protect the Brain
Cannabidiol alcohol use disorder treatment shows promise in reducing addiction severity and protecting against alcohol-related brain damage. Emerging research highlights CBD's neuroprotective effects and potential as an adjunct therapy. Clinical trials…